Implementation of European standards of care for cystic fibrosis - Control and treatment of infection
Implementation of European standards of care for cystic fibrosis - Control and treatment of infection
复制标题
DOI:
10.1016/j.jcf.2009.03.001
复制
发表时间:
2009-05-01
影响因子:
5.2
通讯作者:
Bertram, C.
中科院分区:
文献类型:
--
作者:
Elborn, J. S.;Hodson, M.;Bertram, C.
Background: Several guidelines oil infection control and treatment of infection exist for cystic fibrosis (CF) caregivers, although the extent of implementation is variable.Methods: Adherence to European Consensus Guidelines for CF was Studied by sending surveys to named healthcare professionals in 487 European CF centres/units. Qualitative data analysis was performed.Results: A total of 177/547 (32%) Surveys were returned. Infection control policies were implemented by most (77%) respondents. Separation of patients with Burkholderia cepacia was more common in adults (95%) than children (9%), and was implemented by 53% of respondents for Pseudomonas aeruginosa. Nebulised colistin Plus oral ciprofloxacin was the most common (43%) therapy for P. aeruginosa infection. First infections of P aeruginosa were usually treated with inhaled tobramycin; 41% of repondents did not intervene until lung function deteriorated. Most exacerbations were treated for less than the recommended period.Conclusions: European Consensus Guidelines are widely adhered to. Areas for improvement, include: initiating therapy for exacerbations early, separating infected patients and optimising duration of antibiotic therapy. (C) 2009 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.